154 related articles for article (PubMed ID: 24074052)
1. Probing structural requirements of positive allosteric modulators of the M4 muscarinic receptor.
Huynh T; Valant C; Crosby IT; Sexton PM; Christopoulos A; Capuano B
J Med Chem; 2013 Oct; 56(20):8196-200. PubMed ID: 24074052
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and pharmacological evaluation of M4 muscarinic receptor positive allosteric modulators derived from VU10004.
Huynh T; Valant C; Crosby IT; Sexton PM; Christopoulos A; Capuano B
ACS Chem Neurosci; 2015 Jun; 6(6):838-44. PubMed ID: 25857219
[TBL] [Abstract][Full Text] [Related]
3. New insights into the function of M4 muscarinic acetylcholine receptors gained using a novel allosteric modulator and a DREADD (designer receptor exclusively activated by a designer drug).
Nawaratne V; Leach K; Suratman N; Loiacono RE; Felder CC; Armbruster BN; Roth BL; Sexton PM; Christopoulos A
Mol Pharmacol; 2008 Oct; 74(4):1119-31. PubMed ID: 18628403
[TBL] [Abstract][Full Text] [Related]
4. Impact of species variability and 'probe-dependence' on the detection and in vivo validation of allosteric modulation at the M4 muscarinic acetylcholine receptor.
Suratman S; Leach K; Sexton P; Felder C; Loiacono R; Christopoulos A
Br J Pharmacol; 2011 Apr; 162(7):1659-70. PubMed ID: 21198541
[TBL] [Abstract][Full Text] [Related]
5. Development of a radioligand, [(3)H]LY2119620, to probe the human M(2) and M(4) muscarinic receptor allosteric binding sites.
Schober DA; Croy CH; Xiao H; Christopoulos A; Felder CC
Mol Pharmacol; 2014 Jul; 86(1):116-23. PubMed ID: 24807966
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms of action and in vivo validation of an M4 muscarinic acetylcholine receptor allosteric modulator with potential antipsychotic properties.
Leach K; Loiacono RE; Felder CC; McKinzie DL; Mogg A; Shaw DB; Sexton PM; Christopoulos A
Neuropsychopharmacology; 2010 Mar; 35(4):855-69. PubMed ID: 19940843
[TBL] [Abstract][Full Text] [Related]
7. Probe dependence in the allosteric modulation of a G protein-coupled receptor: implications for detection and validation of allosteric ligand effects.
Valant C; Felder CC; Sexton PM; Christopoulos A
Mol Pharmacol; 2012 Jan; 81(1):41-52. PubMed ID: 21989256
[TBL] [Abstract][Full Text] [Related]
8. The role of transmembrane domain 3 in the actions of orthosteric, allosteric, and atypical agonists of the M4 muscarinic acetylcholine receptor.
Leach K; Davey AE; Felder CC; Sexton PM; Christopoulos A
Mol Pharmacol; 2011 May; 79(5):855-65. PubMed ID: 21300722
[TBL] [Abstract][Full Text] [Related]
9. Reverse engineering of the selective agonist TBPB unveils both orthosteric and allosteric modes of action at the M₁ muscarinic acetylcholine receptor.
Keov P; Valant C; Devine SM; Lane JR; Scammells PJ; Sexton PM; Christopoulos A
Mol Pharmacol; 2013 Sep; 84(3):425-37. PubMed ID: 23798605
[TBL] [Abstract][Full Text] [Related]
10. An allosteric potentiator of M4 mAChR modulates hippocampal synaptic transmission.
Shirey JK; Xiang Z; Orton D; Brady AE; Johnson KA; Williams R; Ayala JE; Rodriguez AL; Wess J; Weaver D; Niswender CM; Conn PJ
Nat Chem Biol; 2008 Jan; 4(1):42-50. PubMed ID: 18059262
[TBL] [Abstract][Full Text] [Related]
11. Antipsychotic drug-like effects of the selective M4 muscarinic acetylcholine receptor positive allosteric modulator VU0152100.
Byun NE; Grannan M; Bubser M; Barry RL; Thompson A; Rosanelli J; Gowrishankar R; Kelm ND; Damon S; Bridges TM; Melancon BJ; Tarr JC; Brogan JT; Avison MJ; Deutch AY; Wess J; Wood MR; Lindsley CW; Gore JC; Conn PJ; Jones CK
Neuropsychopharmacology; 2014 Jun; 39(7):1578-93. PubMed ID: 24442096
[TBL] [Abstract][Full Text] [Related]
12. Thiochrome enhances acetylcholine affinity at muscarinic M4 receptors: receptor subtype selectivity via cooperativity rather than affinity.
Lazareno S; Dolezal V; Popham A; Birdsall NJ
Mol Pharmacol; 2004 Jan; 65(1):257-66. PubMed ID: 14722259
[TBL] [Abstract][Full Text] [Related]
13. Hybrid ortho/allosteric ligands for the adenosine A(1) receptor.
Narlawar R; Lane JR; Doddareddy M; Lin J; Brussee J; Ijzerman AP
J Med Chem; 2010 Apr; 53(8):3028-37. PubMed ID: 20345101
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and pharmacological evaluation of analogues of benzyl quinolone carboxylic acid (BQCA) designed to bind irreversibly to an allosteric site of the M ₁ muscarinic acetylcholine receptor.
Davie BJ; Valant C; White JM; Sexton PM; Capuano B; Christopoulos A; Scammells PJ
J Med Chem; 2014 Jun; 57(12):5405-18. PubMed ID: 24856614
[TBL] [Abstract][Full Text] [Related]
15. Discovery and Development of Muscarinic Acetylcholine M
Takai K; Enomoto T
Chem Pharm Bull (Tokyo); 2018; 66(1):37-44. PubMed ID: 29311510
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and characterization of novel 2-amino-3-benzoylthiophene derivatives as biased allosteric agonists and modulators of the adenosine A(1) receptor.
Valant C; Aurelio L; Devine SM; Ashton TD; White JM; Sexton PM; Christopoulos A; Scammells PJ
J Med Chem; 2012 Mar; 55(5):2367-75. PubMed ID: 22315963
[TBL] [Abstract][Full Text] [Related]
17. Discovery of [
Tong L; Li W; Lo MM; Gao X; Wai JM; Rudd M; Tellers D; Joshi A; Zeng Z; Miller P; Salinas C; Riffel K; Haley H; Purcell M; Holahan M; Gantert L; Schubert JW; Jones K; Mulhearn J; Egbertson M; Meng Z; Hanney B; Gomez R; Harrison ST; McQuade P; Bueters T; Uslaner J; Morrow J; Thomson F; Kong J; Liao J; Selyutin O; Bao J; Hastings NB; Agrawal S; Magliaro BC; Monsma FJ; Smith MD; Risso S; Hesk D; Hostetler E; Mazzola R
J Med Chem; 2020 Mar; 63(5):2411-2425. PubMed ID: 32101422
[TBL] [Abstract][Full Text] [Related]
18. Structural determinants of allosteric agonism and modulation at the M4 muscarinic acetylcholine receptor: identification of ligand-specific and global activation mechanisms.
Nawaratne V; Leach K; Felder CC; Sexton PM; Christopoulos A
J Biol Chem; 2010 Jun; 285(25):19012-21. PubMed ID: 20406819
[TBL] [Abstract][Full Text] [Related]
19. Centrally active allosteric potentiators of the M4 muscarinic acetylcholine receptor reverse amphetamine-induced hyperlocomotor activity in rats.
Brady AE; Jones CK; Bridges TM; Kennedy JP; Thompson AD; Heiman JU; Breininger ML; Gentry PR; Yin H; Jadhav SB; Shirey JK; Conn PJ; Lindsley CW
J Pharmacol Exp Ther; 2008 Dec; 327(3):941-53. PubMed ID: 18772318
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the novel positive allosteric modulator, LY2119620, at the muscarinic M(2) and M(4) receptors.
Croy CH; Schober DA; Xiao H; Quets A; Christopoulos A; Felder CC
Mol Pharmacol; 2014 Jul; 86(1):106-15. PubMed ID: 24807965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
